Medical Care in China

Kidney cancer
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Comprehensive Coverage of Urinary DiseasesKidney, bladder, prostate, and urinary tract diseases can all be assessed.
Treatment of complex stonesSelect a minimally invasive treatment plan based on the characteristics of the stones.
Urinary tumor treatmentcovers tumors of the prostate, bladder, kidneys and urinary tract.
Precise medication therapySome prostate cancer patients can be evaluated for PSMA-related treatment.

Condition Guide

About Kidney cancer

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Renal cell carcinoma is a malignant tumor originating from the renal tubular epithelium. Early stages often present with no obvious symptoms and are frequently discovered incidentally during routine ultrasound or CT scans. Typical symptoms include lower back pain, hematuria, and an abdominal mass. Treatment is centered on surgery—for localized tumors, the goal is to "remove only the tumor and preserve the kidney"; for mid-to-late stages, surgery is combined with targeted and immunotherapies. Today, robotic precision surgery and combined "targeted + immunotherapy" regimens have significantly prolonged patient survival, making early-stage kidney preservation and late-stage life extension the mainstream approach.


Cutting-edge high-precision diagnostic and treatment technologies

  1. Robotic kidney-preserving surgery : The da Vinci robotic arm precisely removes and sutures tumors under 3D high-definition guidance. Multiple hospitals have adopted the "zero ischemia" technology to achieve nearly 100% preservation of kidney function after surgery. The single center has performed more than 600 kidney-preserving surgeries.
  2. First-line TKI combined with immunotherapy : In the CLEAR study, lenvatinib plus pembrolizumab as first-line treatment for advanced renal cell carcinoma achieved a median progression-free survival of 23.9 months (compared to 9.2 months for sunitinib), reducing the risk of progression or death by approximately 53%.
  3. Postoperative adjuvant immunotherapy : KEYNOTE-564 five-year follow-up showed that pembrolizumab adjuvant therapy reduced the risk of recurrence or death by approximately 29% (DFS HR=0.71), with a 5-year disease-free survival rate of 60.9%, which is an NCCN Class 1 recommendation;
  4. Minimally invasive ablation to preserve the kidney : For small-volume tumors, in elderly patients or those with weak constitutions, minimally invasive ablation methods such as radiofrequency/cryoablation can be selected to further reduce trauma.

Care Overview

Kidney cancer Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Li Hang

Professor , specializing in diabetic nephropathy and hypertensive nephropathy

Urology

Research focus: Clinical diagnosis and treatment of primary and secondary kidney diseases, with a focus on diabetic nephropathy and hypertensive nephropathy. Cutting-edge technology: Primarily engaged in the clinical diagnosis and treatment of various primary and secondary kidney diseases, specializing in the treatment of refractory nephrotic syndrome, IgA nephropathy, membranous nephropathy, lupus nephritis, and other diseases. Diseases specializing in: refractory nephrotic syndrome, IgA nephropathy, mem

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Song Bin

Former Director of Radiology Department, Professor/Doctoral Supervisor, President of the Asian Society of Abdominal Radiology

Urology

Research areas : Abdominal imaging diagnosis (liver, gallbladder, pancreas, spleen, gastrointestinal tract, portal venous system); early screening, diagnosis, and prognostic classification of liver cancer. Cutting-edge technologies: The "West China Solution" for early screening and diagnosis of liver cancer using imaging (a new standard for liver cancer diagnosis and a screening model for high-risk groups based on MR functional imaging); a new multimodal imaging prognostic classification for liver cancer;

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Zhang Ling

Chief Physician, Associate Professor, Master's Supervisor, Deputy Director of Nephrology, and Head of the CRRT Subspecialty Group

Urology

-Research areas : complications of hemodialysis, acute kidney injury and critical blood purification technology; CRRT anticoagulation technology. - Cutting-edge technologies: individualized CRRT dosage for severe cases, early warning model for critical AKI, and the world's first local citrate anticoagulation technology with calcium-containing replacement fluid; comprehensive treatment for severe AKI. - Areas of expertise: ICU severe acute kidney injury, septic kidney injury, renal replacement therapy for

West China Hospital of Sichuan University logo Affiliated Hospital West China Hospital of Sichuan University
Chen Yumei

Associate Chief Physician, PhD, Deputy Director of the Department of Nuclear Medicine

Urology

-Research areas : Molecular imaging of tumors, PSMA PET assessment of prostate cancer; - Areas of expertise: Ga-PSMA PET/CT image analysis, lesion interpretation, and semi-quantitative assessment of PSMA expression; - Areas of expertise: Initial staging of prostate cancer, biochemical recurrence localization, and RLT efficacy evaluation; - Academic Highlights & Core Values: Backbone in molecular imaging for prostate cancer, involved in multicenter clinical studies related to PSMA, and optimized PSMA imagi

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Zhang Weiming

Chief Physician, Master's Supervisor, Deputy Director of Nephrology, and Head of the Vascular Access Subspecialty Group.

Urology

Research areas : Hypertensive nephropathy, gouty nephropathy, urinary tract infections, and establishment and maintenance of hemodialysis access. Cutting-edge technologies: Over 5000 arteriovenous fistula surgeries have been performed, with a primary patency rate of 92% one year post-surgery; innovative ultrasound-guided balloon dilation has been used to treat fistula stenosis, avoiding secondary surgical trauma for patients; RAAS blockers combined with uric acid management have been applied to hypertensi

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Ni Zhaohui

Chief Physician, Professor, Doctoral Supervisor, Chief Expert of Renji Hospital, Director of the Department of Internal Medicine, and Academic Leader of Nephrology.

Urology

Research Areas : Diagnosis and treatment of various primary and secondary complex and critical kidney diseases, especially lupus nephritis, diabetic nephropathy, IgA nephropathy, and acute and chronic renal failure. Cutting-Edge Technologies: Pioneered the implementation of a combined assessment model of renal pathology, clinical practice, and molecular subtyping in China, significantly improving the remission rate of IgA nephropathy and lupus nephritis; led the construction of the first home dialysis tra

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Patient Stories

See the Next Step Through Patient Journeys

Complete Placenta Previa with Placenta Accreta - Defused the CASE 01
PATIENT JOURNEY

Complete Placenta Previa with Placenta Accreta - Defused the "Time Bomb" Between Mother and Infant

UrologyObstetrics & Gynecology

Patient records Name: Sari Dewi Age: 32 Nationality: Indonesia Diagnosis: Complete placenta previa complicated by placenta accreta Treatment Hospital: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology “The doctor told me that my placenta, like a tree root, had penetrated my uterus and grown onto my bladder. The risk of severe bleeding during childbirth is extremely high, and I might not even survive.” Sari, 32, from Surabaya, Indonesia, is a mother of two. Her voice

View case details →
Severe Stress Urinary Incontinence After Radical Prostatectomy - The Ultimate Weapon Against CASE 02
PATIENT JOURNEY

Severe Stress Urinary Incontinence After Radical Prostatectomy - The Ultimate Weapon Against "Social Cancer"

RehabilitationUrology

Patient records Name: Somsak Charoen Age: 62 Nationality: Thailand (Bangkok) Diagnosis: Severe stress urinary incontinence after radical prostatectomy (using more than 5 urinal pads daily, severely impacting social life). Treatment Hospital: Department of Urology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology In the video sent by Mr. Charoen, he is wearing a sharp suit and confidently giving a speech at a business conference in Bangkok. His demeanor is

View case details →
Complex vesicovaginal fistula - Restoring CASE 03
PATIENT JOURNEY

Complex vesicovaginal fistula - Restoring "leaked" dignity

UrologyObstetrics & Gynecology

Patient records Name: Nguyen Thi Lan Age: 45 Nationality: Vietnam (Ho Chi Minh City) Diagnosis: Complex vesicovaginal fistula (post-hysterectomy complication, fistula opening approximately 1.5cm, located near the trigone of the bladder) Treatment Hospital: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine—Department of Urology/Obstetrics and Gynecology In the video Ms. Lan sent, she was wearing a beautiful ao dai, smiling and posing for photos on the streets of Ho Chi Minh Cit

View case details →
Benign Prostatic Hyperplasia - Reshaping the CASE 04
PATIENT JOURNEY

Benign Prostatic Hyperplasia - Reshaping the "Valve" of Life

Urology

Patient records Name: Budi Santoso Age: 68 Nationality: Indonesia (Surabaya) Diagnosis: Benign prostatic hyperplasia (prostate volume approximately 120 ml, IPSS score 28, recurrent acute urinary retention) Treatment Hospital: Department of Urology, West China Hospital of Sichuan University Mr. Santoso, a retired captain from Surabaya, had spent his life battling the waves, displaying unwavering resilience. However, in his later years, he succumbed to an unseen "enemy"—his prostate. This small organ swell

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.